Key Takeaways
- Life sciences objective interrogator IQVIA's second-quarter results hit analysts' expectations for gross and nett income.
- The institution besides raised its full-year guidance.
- IQVIA said its exertion and analytics products were awesome maturation drivers.
- IQVIA's banal roseate astir 7% successful intraday trading Monday to move into affirmative territory for nan year.
IQVIA Holdings (IQV) hit second-quarter net expectations and raised its full-year outlook connected Monday, sending shares higher.
The life sciences objective investigation and analytics statement posted adjusted earnings per stock (EPS) of $2.64, topping analysts’ expectations of $2.57, per Visible Alpha. Revenue was $3.81 billion, supra projections of $3.79 billion.
Growth Driven by Technology & Analytics Solutions Unit
The results were driven by IQVIA’s Technology & Analytics Solutions (TAS) segment, which posted year-over-year income maturation of 2.7% to $1.5 billion.
“IQVIA delivered second-quarter results astatine nan precocious extremity of our guidance, driven chiefly by better-than-expected TAS performance," Chief Executive Officer (CEO) Ari Bousbib said.
Looking ahead, IQVIA narrowed its full-year gross guidance to a scope of $15.43 cardinal to $15.53 cardinal from its anterior forecast of $15.33 cardinal to $15.58 billion. It besides raised its adjusted EPS outlook to betwixt $11.10 and $11.30 from $10.95 to $11.25.
Shares of IQVIA jumped 6.6% to $239.45 arsenic of 1:41 p.m. ET Monday to move into affirmative territory year-to-date.